Trial Profile
Study assessing the association of single nucleotide polymorphisms of genes in CCL5/CCR5 pathway with the clinical outcomes in patients with refractory metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Mar 2017
Price :
$35
*
At a glance
- Drugs Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 20 Mar 2017 New trial record
- 21 Jan 2017 Results presented at the 2017 Gastrointestinal Cancers Symposium